X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs WOCKHARDT LTD. - Comparison Results

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES WOCKHARDT LTD. ALKEM LABORATORIES/
WOCKHARDT LTD.
 
P/E (TTM) x - -11.3 - View Chart
P/BV x 6.7 2.2 298.1% View Chart
Dividend Yield % 0.6 1.5 44.1%  

Financials

 ALKEM LABORATORIES   WOCKHARDT LTD.
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
WOCKHARDT LTD.
Mar-17
ALKEM LABORATORIES/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs1,5891,129 140.7%   
Low Rs1,232627 196.5%   
Sales per share (Unadj.) Rs417.5363.1 115.0%  
Earnings per share (Unadj.) Rs56.3-20.4 -275.3%  
Cash flow per share (Unadj.) Rs64.7-7.0 -927.7%  
Dividends per share (Unadj.) Rs12.7010.00 127.0%  
Dividend yield (eoy) %0.91.1 79.1%  
Book value per share (Unadj.) Rs292.9301.8 97.1%  
Shares outstanding (eoy) m119.57110.55 108.2%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x3.42.4 139.7%   
Avg P/E ratio x25.1-42.9 -58.3%  
P/CF ratio (eoy) x21.8-125.9 -17.3%  
Price / Book Value ratio x4.82.9 165.5%  
Dividend payout %22.6-48.9 -46.1%   
Avg Mkt Cap Rs m168,65397,063 173.8%   
No. of employees `000NA6.8 0.0%   
Total wages/salary Rs m9,1719,665 94.9%   
Avg. sales/employee Rs ThNM5,931.8-  
Avg. wages/employee Rs ThNM1,428.1-  
Avg. net profit/employee Rs ThNM-334.0-  
INCOME DATA
Net Sales Rs m49,91540,146 124.3%  
Other income Rs m1,6451,143 144.0%   
Total revenues Rs m51,56141,289 124.9%   
Gross profit Rs m8,482128 6,626.8%  
Depreciation Rs m1,0061,489 67.5%   
Interest Rs m6712,253 29.8%   
Profit before tax Rs m8,451-2,472 -341.9%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,606-211 -760.8%   
Profit after tax Rs m6,731-2,260 -297.8%  
Gross profit margin %17.00.3 5,329.8%  
Effective tax rate %19.08.5 222.5%   
Net profit margin %13.5-5.6 -239.5%  
BALANCE SHEET DATA
Current assets Rs m27,06246,160 58.6%   
Current liabilities Rs m15,32419,258 79.6%   
Net working cap to sales %23.567.0 35.1%  
Current ratio x1.82.4 73.7%  
Inventory Days Days67101 66.0%  
Debtors Days Days4194 43.9%  
Net fixed assets Rs m12,61040,165 31.4%   
Share capital Rs m239553 43.3%   
"Free" reserves Rs m34,49032,814 105.1%   
Net worth Rs m35,02733,367 105.0%   
Long term debt Rs m1,21231,903 3.8%   
Total assets Rs m54,38789,687 60.6%  
Interest coverage x13.6-0.1 -14,004.4%   
Debt to equity ratio x01.0 3.6%  
Sales to assets ratio x0.90.4 205.0%   
Return on assets %13.60 -158,519.6%  
Return on equity %19.2-6.8 -283.7%  
Return on capital %24.9-0.3 -7,415.1%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,5639,121 72.0%   
Fx outflow Rs m3,0122,133 141.2%   
Net fx Rs m3,5526,988 50.8%   
CASH FLOW
From Operations Rs m7,259-2,695 -269.4%  
From Investments Rs m1,864-6,863 -27.2%  
From Financial Activity Rs m-9,27312,545 -73.9%  
Net Cashflow Rs m-1503,010 -5.0%  

Share Holding

Indian Promoters % 66.9 74.5 89.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 2.3 1,439.1%  
FIIs % 0.0 7.7 -  
ADR/GDR % 0.0 0.1 -  
Free float % 0.0 15.4 -  
Shareholders   68,381 67,757 100.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUVEN LIFE  SUN PHARMA  PIRAMAL ENTERPRISES  FDC LTD.  SHASUN PHARMA  

Compare ALKEM LABORATORIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Analysis of IPOs Launched in 2018, Governments Effort to Boost Aviation Infrastructure and Key Stocks in Action Today(Pre-Open)

The returns from initial public offers (IPOs) launched in 2018 are mixed. Comparing the gain/ (loss) since the listing date as mentioned in the last column, seven stocks are in the negative territory.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jun 21, 2018 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - IPCA LABS COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS